DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

49.34 -2.16 (-4.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $49.34 -4.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.19
Previous Close $51.50
Daily Range $48.48 - $51.48
52-Week Range $13.11 - $56.18
Market Cap $4.2B
P/E Ratio -79.23
Dividend (Yield) $0.00 (0.0%)
Volume 913,508
Average Daily Volume 887,325
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary Rss Feed

NBIX's Top Competitors

NBIX $49.34 (-4.19%)
Current stock: NBIX
AMGN $165.54 (4.38%)
Current stock: AMGN
GILD $110.54 (-2.03%)
Current stock: GILD
BIIB $309.43 (3.13%)
Current stock: BIIB